Package 82381-2174-2

Brand: brenzavvy

Generic: bexagliflozin
NDC Package

Package Facts

Identity

Package NDC 82381-2174-2
Digits Only 8238121742
Product NDC 82381-2174
Product ID 82381-2174_057c1420-60f7-4a86-922c-44b37df317f6
Description

90 TABLET in 1 BOTTLE (82381-2174-2)

Marketing

Marketing Status
Marketed Since 2023-07-13
Brand brenzavvy
Generic bexagliflozin
Sample Package No

Linked Drug Pages (1)

BRENZAVVY ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "057c1420-60f7-4a86-922c-44b37df317f6", "openfda": {"nui": ["N0000187059", "N0000187058"], "unii": ["EY00JF42FV"], "rxcui": ["2637859", "2637865"], "spl_set_id": ["3cdf28fc-4194-4ad6-aa03-c9eaa68da83e"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["TheracosBio, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (82381-2174-1)", "package_ndc": "82381-2174-1", "marketing_start_date": "20230713"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (82381-2174-2)", "package_ndc": "82381-2174-2", "marketing_start_date": "20230713"}], "brand_name": "BRENZAVVY", "product_id": "82381-2174_057c1420-60f7-4a86-922c-44b37df317f6", "dosage_form": "TABLET", "pharm_class": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "82381-2174", "generic_name": "Bexagliflozin", "labeler_name": "TheracosBio, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BRENZAVVY", "active_ingredients": [{"name": "BEXAGLIFLOZIN", "strength": "20 mg/1"}], "application_number": "NDA214373", "marketing_category": "NDA", "marketing_start_date": "20230713", "listing_expiration_date": "20261231"}